Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J.R. Geigy was a pioneering Swiss chemical and pharmaceutical company founded in 1758 in Basel. The firm initially specialized in chemicals and dyes before transitioning into a global pharmaceutical powerhouse in the 20th century. It is historically significant for developing major drugs such as the antidepressant Tofranil, the anticonvulsant Tegretol, and the insecticide DDT, for which researcher Paul Müller won a Nobel Prize. In 1970, J.R. Geigy merged with Ciba to form Ciba-Geigy, which later merged with Sandoz in 1996 to create Novartis. Today, the legacy of Geigy remains a foundational component of Novartis's heritage and the Swiss life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on J.R. Geigy.